Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
StockCIK 1534248

Chemomab Therapeutics Ltd. (CMMB): Insider Trades and Fund Holdings

In the past 12 months, Chemomab Therapeutics Ltd. insiders reported 0 open-market purchases worth $0 and 2 sales worth $7K; 0 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$7KSold by insiders, 12 months
0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 1, 2026.

Recent CMMB insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Sep 1Aug 27Neil Harris CohenDirectorDirector▼ SELL1,3042.85$4K−3.7%Form 4 ↗
Sep 1Aug 28Neil Harris CohenDirectorDirector▼ SELL1,0002.80$3K−2.9%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Neil Harris CohenDirector0$02$7KSep 1, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →